CONNECT WITH US
HealthTech

HealthTech

ODAIA Raises $15M, Scaling Predictive Pharma Commercial Intelligence Across Enterprise Portfolios

HIT Consultant logo

Published on

Add as a preferred source on Google
ODAIA Raises $15M, Scaling Predictive Pharma Commercial Intelligence Across Enterprise Portfolios

Predictive pharmaceutical commercial intelligence company ODAIA raises $15M Series C financing round led by Monograph Capital and anchored by strategic investor PHM , the leading U.S. health media agency and part of Publicis Groupe.

Returning institutional investors participating in the Series C include Series A backers BDC Capital, Flint Capital , Innospark Ventures , and Graphite Ventures, alongside Series B investors Threshold Ventures and Wittington Ventures .

Alongside the equity investment, ODAIA executed a commercial Platform Agreement naming PHM as its exclusive agency partner in the United States to connect digital media activation with field sales coordination across pharmaceutical brands.

ODAIA’s commercial intelligence platform addresses data fragmentation inside biopharmaceutical enterprises—where brand, marketing, and field teams operate from disconnected views of the same healthcare professional (HCP)—by unifying prescribing telemetry, field sales activity, and digital engagement into a single HCP record.

ODAIA’s platform establishes a unified commercial intelligence foundation that integrates disparate prescribing data, field sales activity, and digital engagement signals into a single longitudinal view of each physician. Rather than requiring data science teams to rebuild models for every product launch, brand leaders codify commercial objectives once inside Brand Strategy Studio, allowing ODAIA’s decision engines to translate that strategy into physician-level execution across therapeutic areas through configuration rather than custom engineering.

Using predictive machine learning to analyze patient journey trajectories, the platform identifies physicians whose patient panels are likely to require a specific therapy—often months before formal diagnoses appear in standard claims or electronic health record feeds. That intelligence flows simultaneously into two operational layers: Field Intelligence delivers prioritized, dynamic call plans directly into field representatives’ existing CRM workflows, while Marketing Intelligence orchestrates individualized, sequenced HCP journeys across digital media and partner channels.


Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.